Learn more →
Back to Expert Scholars
AI in Cancer Research / AI+癌症研究AI Medical Imaging

Andrew Lin

安德鲁·林

MBBS, BMedSc, PhD, FRACP, FSCCT

🏢Victorian Heart Hospital / Monash University(维多利亚心脏医院/莫纳什大学)🌐Australia

Academic Lead, Non-Invasive Imaging; National Heart Foundation Fellow无创影像学术带头人;国家心脏基金会研究员

1
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Andrew Lin, MBBS, PhD, FRACP, FSCCT is an emerging leader in AI for cardiac CT whose international multicenter validation work has advanced deep learning for coronary disease assessment. Trained at Cedars-Sinai with Dey and Slomka, he now leads non-invasive imaging at Victoria's first dedicated heart hospital. His 2022 Lancet Digital Health paper validated deep learning coronary plaque quantification across diverse populations.

Andrew Lin医学学士、哲学博士、FRACP、FSCCT是心脏CT AI领域的新兴领袖,他的国际多中心验证工作推进了冠状动脉疾病评估的深度学习。他在西达斯-西奈与Dey和Slomka一起培训,现在领导维多利亚第一家专门心脏医院的无创影像。他2022年在《柳叶刀数字健康》上的论文验证了跨不同人群的深度学习冠状动脉斑块量化。

Share:

🧪Research Fields 研究领域

Coronary CT AI冠状动脉CT AI
Plaque Quantification斑块量化
Multicenter Validation多中心验证
Pericoronary Fat冠周脂肪

🎓Key Contributions 主要贡献

Multicenter AI Validation

Led international validation of deep learning for coronary CT angiography plaque and stenosis quantification

Pericoronary Fat Radiomics

Pioneered radiomic analysis of pericoronary fat for vascular inflammation assessment

Representative Works 代表性著作

[1]

Deep learning-enabled coronary CT angiography for plaque and stenosis quantification

The Lancet Digital Health (2022)

International multicenter validation of deep learning for coronary CT analysis

🏆Awards & Recognition 奖项与荣誉

🏆SCCT Young Investigator Award (1st place)
🏆National Heart Foundation Postdoctoral Fellow
🏆NHMRC Scholarship

📄Data Sources 数据来源

Last updated: 2026-03-12 | All information from publicly available academic sources

关注 安德鲁·林 的研究动态

Follow Andrew Lin's research updates

留下邮箱,当我们发布与 Andrew Lin(Victorian Heart Hospital / Monash University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment